July 1, 2008 - CryoCath Technologies introduced the Arctic Front in Italy, Belgium and Spain, aiming to provide better treatment of paroxysmal atrial fibrillation (PAF) with its cryoablation balloon catheter that allows physicians to isolate all four pulmonary veins.
The Arctic Front is a minimally invasive cryo-balloon catheter designed specifically to treat paroxysmal Atrial Fibrillation. This bi-directional, double balloon catheter enables physicians to rapidly isolate all four pulmonary veins for the treatment of AFib. More than 2,600 patients have been treated in more than 45 centres across Europe.
Prof. Dr. Claudio Tondo, Chief of the Cardiology Division and Director of the Cardiac Arrhythmia and Heart Failure Research Institute at the San Camillo-Forlanini Hospital in Rome, Italy, performed the first procedures with Arctic Front in Italy June 9, 2008. Dr. Tondo will provide leadership for the program in Italy, the second largest electrophysiology market in continental Europe.
The first Arctic Front procedures in Belgium were performed in May 2008, by Prof. Dr. Pedro Brugada, Head of the Heart Rhythm Management Centre, UZ Brussel - Vrije Universiteit Brussel and Dr. Gian Battista Chierchia, Director Atrial Fibrillation and Pacing Program. Drs. Brugada and Chierchia have treated four patients in Brussels to date.
Prof. Dr. Julian Villacastin and his team at Hospital Clinico San Carlos in Madrid, Spain have treated two patients since first using Arctic Front on June 24, 2008. The patients treated to date have had successful outcomes and no safety concerns have been reported.
For more information: www.cryocath.com